Displaying posts published in

March 2018

No New Special Counsel By Andrew C. McCarthy

Sessions should appoint a Justice Department prosecutor to investigate the investigators.

‘What’s good for the goose . . .” is more an understandable impulse than a useful rule of thumb in legal controversies, particularly legal controversies in which an error has been made.

The White House and congressional Republicans have watched in ire as the Trump administration has been tied in knots by the no-boundaries Mueller investigation. “Okay,” they’re thinking, “now, it’s payback time.” There appear to have been highly irregular investigative tactics used in probing the Trump campaign — particularly, but not exclusively, by the Obama administration. Why not, then, appoint another special counsel to squeeze the squeezers? Why not turn the tables?

It’s a bad idea.

Original Sin: A Prosecutor but No Crime
Deputy Attorney General Rod Rosenstein made a foundational error in appointing Robert Mueller to be special counsel to investigate . . . well . . . um . . . come to think of it, that was the error: The investigation has no parameters, and thus no limitations.

Investigations conducted by prosecutors are supposed to be rooted in known crimes — or, at the very least, articulable suspicion that known crimes have occurred. Under the governing regulations, to justify the appointment of a special counsel, those crimes must form the basis for two salient findings: (1) that the Justice Department has a conflict of interest so severe that it cannot conduct the investigation in the normal manner, and (2) that it is necessary to appoint, from outside the Justice Department, a quasi-independent prosecutor. This special prosecutor is to be given a grant of investigative jurisdiction limited to the crimes that the Justice Department is too conflicted to investigate — and no other crimes, unless the special counsel explicitly requests, and the Justice Department grants, an expansion of jurisdiction. (See here, where I address Paul Manafort’s claim that his indictment violates regulations limiting special-counsel jurisdiction.)

TRUMP ON TRIAL – OR KANGAROO COURT? MELANIE PHILLIPS

This evening, I attended a panel discussion at Jewish Book Week in London entitled “Trump on trial”. The three panel members were all distinguished writers who viscerally loathe US President Donald Trump. What follows is an account of highlights of this discussion which I provide without further comment.

The first panellist was historian Simon Schama, who immediately after Trump’s election called it a “cataclysmic moment” and said “democracy often brings fascists to power, it did in Germany in the 1930s”.

The second was Guardian journalist Jonathan Freedland whose new thriller To Kill the President, written under the name Sam Bourne, imagines an assassination plot hatched against a volatile demagogue in the White House – who does things like tweet, lie and grab a female aide by her genitals – for fear that he intends to launch a nuclear attack.

The third was novelist Howard Jacobson, whose latest novel Pussy, written in a “fury of disbelief” about Trump’s election, is a “comic fairytale” about a man called Prince Fricassus who imagines himself to be the Roman Emperor Nero, fantasises about hookers, is idle, boastful, thin-skinned and egotistic and has no manners, curiosity, knowledge, idea or words in which to express them – and who may therefore be the very man to lead his country.

Noting that the panel contained no Trump defender, the chairman Jonny Geller asked the three to identify two good things or successes that Trump had achieved.

Schama replied that Trump was liquidating positive governance in America. He was appointing to critical government agencies people whose “only qualification” was they would destroy them. Thus for example Scott Pruitt, who was appointed head of the Environmental Protection Agency, was “abolishing regulation on toxic chemicals”; Education Secretary Betsy de Vos “doesn’t believe in public education”. Trump was a “deeply disgusting, reprehensible, dangerously unbalanced individual. The only good thing he does is once in every four days he plays golf”.

The House of Windsor and Those Expansionist Jews… by Gerald A. Honigman

The House of Windsor, with Prince William’s projected summer arrival, will make its first official visit to Israel since David Ben-Gurion proclaimed independence on May 14, 1948, a nice birthday present for my own arrival on Planet Earth on May 8th and, coincidentally, also the birthday of the American President who would fight his own State Department in recognizing the resurrected Jewish nation.

In good times and in bad, pre-and post-statehood Israel has been tied to Great Britain.

From the days of 19th and early 20th century British Christian Zionists culminating in Foreign Secretary Lord Balfour’s 1917 Declaration; to the separation of almost 80% of the original land envisioned by Balfour in the post-World War I 1920 Mandate of Palestine (all the land east of the Jordan River) in 1922, engineered by Colonial Secretary Churchill as a gift to Arab nationalism for Hashemite support for London’s war effort; to Lt. General Sir John Bagot Glubb’s British-led Transjordanian Arab Legion’s attack on a reborn Israel in 1948; to London’s White Papers limiting entrance of Jews fleeing for their lives from Nazi gas chambers; etc. and so forth, the Jews’ and the Brits’ histories have been closely intertwined.

Add to this the irony that right now, today, as London joins most others in the United Nations assailing Israel for refusing to return to its pre-’67 war existence as a 1949 armistice line-created, 9-15 mile wide sardine can of a state, it was Great Britain’s own Lord Caradon, the chief architect of the final draft of carefully-worded UNSC Resolution 242 after the ’67 fighting, who saw to it that Israel would not have to return to the status quo ante and withdraw to the ’49 lines. As corroborated by 242’s other architects, like Professor Eugene Rostow, Israel was to get real, more defensible, secure, and (wishful thinking) recognized borders instead.

GOOD NEWS FROM AMAZING ISRAEL FROM MICHAEL ORDMAN

ISRAEL’S MEDICAL ACHIEVEMENTS

Brain bleed detection gets Europe approval. Israel’s Zebra Medical Vision has received EU regulatory approval (i.e. the CE mark) for its new algorithm capable of detecting Intracranial hemorrhages (brain bleeds) from uploaded CT or MRI Scans. http://www.calcalistech.com/ctech/articles/0,7340,L-3733482,00.html

Glucose analyzer gets Europe approval. I reported previously (twice) about Israel’s DreaMed Diabetes monitors for analyzing the data from Continuous Glucose Monitors (CGMs). DreaMed has just received the CE mark from the European Union for its Advisor Pro product.
https://www.timesofisrael.com/israeli-smart-software-harnesses-flood-of-data-to-manage-diabetes-care/
https://www.youtube.com/embed/_eMkeq0lrFc?rel=0

Excellent results for new prostate cancer test. (TY Hazel) I reported previously (July 2016) that Israel’s Micromedic Technologies had good results in an 18-patient trial of its CellDetect prostate cancer diagnosis solution. Latest tests on 59 samples were 80% successful – far exceeding the 25% for existing PSI tests.
https://www.israel21c.org/israeli-breakthrough-in-noninvasive-prostate-cancer-test/

Lifestyle controls your microbiome. Scientists at Israel’s Weizmann Institute have found from a study of over 1,000 Israelis that there is no genetic link to the good bacteria in your gut (microbiome). A person’s health (cholesterol, weight, blood glucose levels etc.) however, can be controlled by maintaining a healthy stomach.
https://wis-wander.weizmann.ac.il/life-sciences/genetics-or-lifestyle-what-it-shapes-our-microbiome

A diagnostic kit on a USB drive. The tech-transfer company of Ben-Gurion University, plus Israeli-founded, Singapore-based Biosensorix, are developing $5 disease diagnosis kits that connect to a smartphone via its USB port. Instead of sending samples for lab tests, medical staff can get immediate blood test results and decide on a course of action. https://www.israel21c.org/new-usb-like-diagnostic-kits-provide-faster-results/

Using AI to analyze biopsies. Israeli startup Nucleai is developing computer vision and artificial intelligence (AI) to help overworked pathologists process and analyze biopsies for cancer quicker and more accurately. Nucleai founders have years of experience of computer vision gained during their IDF service.
https://www.timesofisrael.com/israeli-startup-aims-at-disease-diagnosis-helping-pathologists-process-biopsies/

UK-Israel fund to research aging process. The UK has launched a new £5m fund to promote scientific collaboration and research between Israel and the UK into the aging process. The Britain Israel Research and Academic Exchange (BIRAX) Aging fund will also promote research that into aging-related diseases.
https://www.timesofisrael.com/uk-sets-up-5m-fund-for-collaboration-with-israel-on-aging-process/

$20 million donation for nuclear medicine center. Russian Jewish billionaire Roman Abramovich has donated $20 million to Israel’s Sheba Medical Center to build a new medical center for nuclear medicine and research. Its cyclotron particle accelerator will use radioactive ion beams to pinpoint and kill cancer cells.
http://www.jewishpress.com/news/chessed-and-tzedaka/billionaire-donates-20m-to-israels-sheba-hospital-for-nuclear-medicine-research-center/2018/03/03/